Building a serialization blueprint: early planning drives success
In the complex world of pharmaceuticals, serialization is more than a compliance requirement; it is a foundational element of secure, traceable, and efficient supply chain operations. This webinar explores the crucial role of third-party logistics (3PL) providers in establishing a robust serialization strategy during the early stages of drug development, setting the stage for smooth commercialization.
Join us as pharmaceutical manufacturers come together to share experiences, insights, and strategies. We will delve into best practices for forming early-stage 3PL partnerships and crafting an effective serialization blueprint.
This webinar is an invaluable opportunity for those navigating the pre-commercialization phase to learn from industry veterans, foster partnerships, and lay the groundwork for successful commercialization. Attendees will leave with a comprehensive understanding of the strategic value 3PLs can bring to their serialization journey and a roadmap to commercial success.
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.